Letters to the Editor

Response to "Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy"

Mehdi Nematbakhsh

nephrotoxicity, cisplatin, gender, magnesium, estrogen, antioxidants
CJON 2018, 22(5), 477-478. DOI: 10.1188/18.CJON.477-478

An article by Duffy, Fitzgerald, Boyle, and Rohatgi (2018) was published in the April issue of the Clinical Journal of Oncology Nursing. Based on review, the authors suggested some clinical recommendations to protect the kidneys against cisplatin-induced nephrotoxicity, including hydration or supplementation of magnesium or mannitol during cisplatin administration. In addition to clinical findings, the related basic sciences data may be helpful in formulating treatment guidelines in cisplatin therapy. This letter will present several suggestions for future clinical studies based on laboratory findings.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.